Connection

Marcelo Vargas to Astrocytes

This is a "connection" page, showing publications Marcelo Vargas has written about Astrocytes.
Connection Strength

5.783
  1. FABP7 upregulation induces a neurotoxic phenotype in astrocytes. Glia. 2020 12; 68(12):2693-2704.
    View in: PubMed
    Score: 0.591
  2. Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1. FASEB J. 2019 06; 33(6):7084-7091.
    View in: PubMed
    Score: 0.539
  3. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr Pharm Des. 2017; 23(33):5010-5021.
    View in: PubMed
    Score: 0.463
  4. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1). J Biol Chem. 2016 May 13; 291(20):10836-46.
    View in: PubMed
    Score: 0.439
  5. Changes in Protein Expression and Lysine Acetylation Induced by Decreased Glutathione Levels in Astrocytes. Mol Cell Proteomics. 2016 Feb; 15(2):493-505.
    View in: PubMed
    Score: 0.426
  6. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G??A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice. PLoS One. 2014; 9(7):e103438.
    View in: PubMed
    Score: 0.391
  7. Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics. 2010 Oct; 7(4):471-81.
    View in: PubMed
    Score: 0.300
  8. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med. 2009 Jun 03; 11:e17.
    View in: PubMed
    Score: 0.274
  9. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci. 2008 Dec 10; 28(50):13574-81.
    View in: PubMed
    Score: 0.265
  10. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J Neurosci Res. 2008 Dec; 86(16):3515-25.
    View in: PubMed
    Score: 0.265
  11. Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J Neurochem. 2006 May; 97(3):687-96.
    View in: PubMed
    Score: 0.219
  12. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J Biol Chem. 2005 Jul 08; 280(27):25571-9.
    View in: PubMed
    Score: 0.206
  13. Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo. 2004 May-Jun; 18(3):269-74.
    View in: PubMed
    Score: 0.193
  14. NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons. FASEB J. 2022 04; 36(4):e22262.
    View in: PubMed
    Score: 0.167
  15. Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model. FASEB J. 2021 02; 35(2):e21343.
    View in: PubMed
    Score: 0.154
  16. Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice. Pharmacol Res Perspect. 2020 08; 8(4):e00636.
    View in: PubMed
    Score: 0.149
  17. Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation. Free Radic Biol Med. 2016 06; 95:112-20.
    View in: PubMed
    Score: 0.110
  18. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci. 2012 Dec 05; 32(49):17775-87.
    View in: PubMed
    Score: 0.087
  19. Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicol Sci. 2010 Jun; 115(2):557-68.
    View in: PubMed
    Score: 0.072
  20. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol Dis. 2010 Mar; 37(3):574-80.
    View in: PubMed
    Score: 0.071
  21. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2933-8.
    View in: PubMed
    Score: 0.067
  22. Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons. J Neurosci Res. 2006 Oct; 84(5):1098-106.
    View in: PubMed
    Score: 0.057
  23. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem. 2005 Apr; 93(1):38-46.
    View in: PubMed
    Score: 0.051
  24. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener Dis. 2005; 2(3-4):139-46.
    View in: PubMed
    Score: 0.050
  25. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev. 2004 Dec; 47(1-3):263-74.
    View in: PubMed
    Score: 0.050
  26. Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo. 2004 May-Jun; 18(3):275-80.
    View in: PubMed
    Score: 0.048
  27. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem. 2004 Apr; 89(2):464-73.
    View in: PubMed
    Score: 0.048
  28. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci. 2008 Dec; 1147:61-9.
    View in: PubMed
    Score: 0.017
  29. Modulation of p75-dependent motor neuron death by a small non-peptidyl mimetic of the neurotrophin loop 1 domain. Eur J Neurosci. 2006 Sep; 24(6):1575-80.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.